Here, we present a protocol to examine how lncPVT1 regulates HIF-1α stability and glycolytic gene expression in thyroid cancer cells, enabling the study of metabolic regulation and potential therapeutic targets.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Research Article
Here, we present a protocol to examine how lncPVT1 regulates HIF-1α stability and glycolytic gene expression in thyroid cancer cells, enabling the study of metabolic regulation and potential therapeutic targets.
As the foremost endocrine system cancer, thyroid carcinoma exhibits an accelerating epidemiological trend across populations. Despite advances in treatment modalities, recurrence and metastasis remain challenges. The long non-coding RNA PVT1 (lncPVT1) has emerged as a conserved oncogenic regulator in multiple cancer types, yet its specific function in TC requires further exploration. Our research focused on examining how lncPVT1 affects glycolysis under both normoxic and hypoxic conditions using TC cell lines TPC-1 and K1. Overexpression of lncPVT1 significantly enhanced glucose consumption and lactate production under hypoxia, corroborating its ability to augment glycolysis. Further, lncPVT1 upregulated key glycolytic genes such as GLUT1, HK1, HK2, and PGK1, and facilitated TC cell proliferation. Mechanistically, lncPVT1 stabilized hypoxia-inducible factor 1α (HIF-1α) by impeding its degradation and leading to its accumulation. This accumulated HIF-1α then bound to specific regulatory sequences that control the expression of genes involved in glycolysis, ultimately activating these genes and boosting glycolytic activity. Our findings demonstrate that lncPVT1 regulates HIF-1α stability and glycolytic gene expression, advancing our understanding of TC metabolism and potentially revealing novel therapeutic targets.
Thyroid cancer (TC), a highly prevalent endocrine malignancy, has experienced a rapid increase in incidence rates1. Despite advancements in therapeutic strategies, including surgical procedures, radiation therapy, and thyroid hormonal suppression therapy, a substantial proportion of TC patients still face the risk of tumor recurrence and metastasis, emphasizing the need for a deeper understanding of its molecular pathogenesis2,3. TC development is associated with several established risk factors, including ionizing radiation exposure, contact with chemical carcinogens, tobacco use, and ....
Access restricted. Please log in or start a trial to view this content.
Cell culture and transfection
Human thyroid carcinoma (TC) cell lines TPC-1 and K1 were cultured in Dulbecco's Modified Eagle Medium (DMEM) containing 4.5 g/L glucose, supplemented with 10% fetal bovine serum and 100 µg/mL penicillin-streptomycin. Cells were maintained at 37 °C in a humidified incubator with 5% CO2. For hypoxia treatment, 1 x 105 cells were transferred to a sealed hypoxic chamber equilibrated with 1% O2, 5% CO2, and 94% N2 at 37 °C for 24 h, unless otherwise specified. Stable overexpression of lncPVT1 (lncPVT1 OE) and the co....
Access restricted. Please log in or start a trial to view this content.
Enhanced glycolysis in TC cell lines mediated by lncPVT1
We initially established lncPVT1 OE and NC in TPC-1 and K1 cells using a lentiviral expression system. Successful overexpression of lncPVT1 was confirmed by qRT-PCR (Figure 1A-B). To evaluate the impact on glycolysis, cells were cultured under normoxia and hypoxia for 24 h. Our findings indicated that hypoxia .......
Access restricted. Please log in or start a trial to view this content.
As the most common endocrine malignancy, TC poses significant challenges in terms of its recurrence and metastasis22. The mechanistic landscape of thyroid carcinogenesis remains incompletely defined, especially regarding lncRNA-mediated regulation of oncogenic metabolic reprogramming and fundamental cellular behaviors23. In this study, we focused on the oncogenic lncPVT1 and its influence on glycolysis and HIF-1α stability in TC cells.
The W.......
Access restricted. Please log in or start a trial to view this content.
The authors assert no conflicts of interest, whether financial or non-financial.
Research funding was provided through the Fujian Science and Technology Plan Project (2022J01784).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| BCA Protein Assay Kit | meilunbio | MA0082-2 | WB Protein Quantification Assay |
| Biosafety Cabinet | Lishen | HFsafe-1200LC | Cell Passage and Expansion |
| Centrifuge | Baiyang | B320A | Centrifuge Cells |
| Chemiluminescence Imaging System | BIO-RAD(USA) | ChemiDoc Touch | WB Development |
| CO2 Incubator | Thermo(USA) | 311 | Cell Culture |
| ECL Chemiluminescence Detection Kit | meilunbio | MA0186-1 | WB Development |
| Flow Cytometer | BD | FACSCalbur | Flow Cytometry Apoptosis Assay |
| Fluorescence Inverted Microscope | NIKON(Japan) | Ts2-FL | Cell Observation |
| Fluorescence Quantitative PCR Instrument | ABI(USA) | 7300 | PCR Experiment |
| GAPDH | proteintech | 60004-1-Ig | WB Internal Reference Antibody |
| Glucose Assay Kit | Jiancheng | A154-1-1 | Biochemical Assay |
| HIF1A | BOSTER | A00013 | WB Antibody |
| HRP-conjugated Affinipure Goat Anti-Mouse IgG(H+L) | proteintech | SA00001-1 | Immunohistochemistry (IHC) Experiment |
| HRP-conjugated Affinipure Goat Anti-Rabbit IgG(H+L) | proteintech | SA00001-2 | Immunohistochemistry (IHC) Experiment |
| K1 cell line | Cell Bank of the Chinese Academy of Sciences (Shanghai, China) | NA | Human papillary thyroid carcinoma cell line |
| Lactic Acid Assay Kit | Jiancheng | A019-2-1 | Biochemical Assay |
| Microplate Reader | Thermo(USA) | K3 | ELISA Detection |
| PAGE Gel Ultra-Fast Preparation Kit (15%) | meilunbio | MA0384 | WB Electrophoresis |
| PCR Instrument | BIO-RAD(USA) | PTC100 | PCR Experiment |
| Pre-stained Rainbow Protein Marker | meilunbio | MA0342 | WB Electrophoresis |
| Protein Vertical Electrophoresis System | BIO-RAD(USA) | POWER PAC 200 | WB Electrophoresis |
| SDS-PAGE Protein Loading Buffer (5X) | Beyotime | P0015L | WB Electrophoresis |
| Sodium Dodecyl Sulfate (SDS) | sigma | 151-21-3 | WB Electrophoresis |
| TPC-1 cell line | Cell Bank of the Chinese Academy of Sciences (Shanghai, China) | NA | Human thyroid carcinoma cell line |
Access restricted. Please log in or start a trial to view this content.